N/A
Manufactured by Xttrium Laboratories, Inc.
120 FDA adverse event reports analyzed
Last updated: 2026-04-15
CHLORHEXIDINE GLUCONATE 4% is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Xttrium Laboratories, Inc.. The most commonly reported adverse reactions for CHLORHEXIDINE GLUCONATE 4% include RASH, HYPERSENSITIVITY, ACCIDENTAL EXPOSURE TO PRODUCT, EYE IRRITATION, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CHLORHEXIDINE GLUCONATE 4%.
Out of 38 classified reports for CHLORHEXIDINE GLUCONATE 4%:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 120 FDA FAERS reports that mention CHLORHEXIDINE GLUCONATE 4%. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include RASH, HYPERSENSITIVITY, ACCIDENTAL EXPOSURE TO PRODUCT, EYE IRRITATION, PAIN, ALOPECIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Xttrium Laboratories, Inc. in connection with CHLORHEXIDINE GLUCONATE 4%. Always verify the specific product and NDC with your pharmacist.